![Renu Vijaya](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Renu Vijaya
Chief Tech/Sci/R&D Officer at Insmed Ltd.
Profile
Renu Vijaya is currently the Chief Medical Officer & EVP-Development at Insmed Ltd.
Prior to this, she held positions as Principal at Bristol Myers Squibb Co., Vice President at Labcorp Drug Development, Inc., Senior Vice President-Development at Agenus, Inc., Vice President at Novartis Corp., Principal at CardioVascular Systems, Inc., Principal at Endocrine Pharmaceuticals Ltd., and Chief Medical Officer & EVP-Development at Transave, Inc. Dr. Vijaya received her undergraduate and doctorate degrees from the University of Zambia.
Renu Vijaya active positions
Companies | Position | Start |
---|---|---|
Insmed Ltd.
![]() Insmed Ltd. Pharmaceuticals: MajorHealth Technology Insmed Ltd. develops and manufactures pharmaceutical products for the treatment of lung diseases. Its products are used for the site-specific treatment of serious lung diseases such as pulmonary infections in cystic fibrosis patients and cancers affecting the lung. The company is located in London, the United Kingdom. | Chief Tech/Sci/R&D Officer | 2009-06-09 |
Former positions of Renu Vijaya
Companies | Position | End |
---|---|---|
Transave, Inc.
![]() Transave, Inc. Pharmaceuticals: MajorHealth Technology Transave, Inc. is a biopharmaceutical company focused on developing innovative, inhaled pharmaceuticals for the site-specific treatment of serious lung diseases such as pulmonary infections in cystic fibrosis patients and cancers affecting the lung. They are committed to significantly improving the quality of life and healthcare of patients suffering from these life-threatening diseases. Its operating principles are centered on teamwork, openness, mutual respect, diversity of opinion, trust, accountability and innovative science. They are developing products based on Transave's proprietary liposomal technology designed specifically for lung delivery. Its focus is on reformulating off-patent, established drugs into unique liposomal technology - based inhaled pharmaceuticals for the localized, site-specific treatment of serious lung diseases. Transave's proprietary liposomal technology allows for the sustained release of a drug in the lung's microenvironment. By remaining in the lungs for a prolonged period and potentially minimizing systemic exposure, Transave's liposomal technology offers the potential for changing the product profile, improving delivery of the compound to the lung and enhancing the therapeutic index of established pharmaceuticals. | Chief Tech/Sci/R&D Officer | 2012-08-29 |
BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
COVANCE INC. | Corporate Officer/Principal | - |
Endocrine Pharmaceuticals Ltd.
![]() Endocrine Pharmaceuticals Ltd. Miscellaneous Commercial ServicesCommercial Services Endocrine Pharmaceuticals Ltd. engages in the development of hormonal drugs. If focuses on the research of micrin a naturally occurring mammalian hormonal inhibitor of tissue masses and cellular integrity. The company is headquartered in Tadley, the United Kingdom. | Corporate Officer/Principal | - |
CardioVascular Systems, Inc. /Old/
![]() CardioVascular Systems, Inc. /Old/ Medical SpecialtiesHealth Technology Cardiovascular Systems, Inc. manufactures and sells cardiopulmonary products. It designs, develops and markets clinical devices for the treatment of cardiovascular disease. The company is located in St. Paul, MN. | Corporate Officer/Principal | - |
Training of Renu Vijaya
University of Zambia | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
AGENUS INC. | Health Technology |
Private companies | 6 |
---|---|
Labcorp Drug Development, Inc.
![]() Labcorp Drug Development, Inc. Pharmaceuticals: MajorHealth Technology Covance, Inc. operates as a contract research organization and drug development company. Its services include research, lead optimization, analysis services, safety assessment and drug safety testing, consulting and partnering, clinical development, informatics, clinical testing, commercialization, and manufacturing support. The company was founded on November 12, 1996 and is headquartered in Princeton, NJ. | Health Technology |
Novartis Corp.
![]() Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Health Technology |
CardioVascular Systems, Inc. /Old/
![]() CardioVascular Systems, Inc. /Old/ Medical SpecialtiesHealth Technology Cardiovascular Systems, Inc. manufactures and sells cardiopulmonary products. It designs, develops and markets clinical devices for the treatment of cardiovascular disease. The company is located in St. Paul, MN. | Health Technology |
Endocrine Pharmaceuticals Ltd.
![]() Endocrine Pharmaceuticals Ltd. Miscellaneous Commercial ServicesCommercial Services Endocrine Pharmaceuticals Ltd. engages in the development of hormonal drugs. If focuses on the research of micrin a naturally occurring mammalian hormonal inhibitor of tissue masses and cellular integrity. The company is headquartered in Tadley, the United Kingdom. | Commercial Services |
Transave, Inc.
![]() Transave, Inc. Pharmaceuticals: MajorHealth Technology Transave, Inc. is a biopharmaceutical company focused on developing innovative, inhaled pharmaceuticals for the site-specific treatment of serious lung diseases such as pulmonary infections in cystic fibrosis patients and cancers affecting the lung. They are committed to significantly improving the quality of life and healthcare of patients suffering from these life-threatening diseases. Its operating principles are centered on teamwork, openness, mutual respect, diversity of opinion, trust, accountability and innovative science. They are developing products based on Transave's proprietary liposomal technology designed specifically for lung delivery. Its focus is on reformulating off-patent, established drugs into unique liposomal technology - based inhaled pharmaceuticals for the localized, site-specific treatment of serious lung diseases. Transave's proprietary liposomal technology allows for the sustained release of a drug in the lung's microenvironment. By remaining in the lungs for a prolonged period and potentially minimizing systemic exposure, Transave's liposomal technology offers the potential for changing the product profile, improving delivery of the compound to the lung and enhancing the therapeutic index of established pharmaceuticals. | Health Technology |
Insmed Ltd.
![]() Insmed Ltd. Pharmaceuticals: MajorHealth Technology Insmed Ltd. develops and manufactures pharmaceutical products for the treatment of lung diseases. Its products are used for the site-specific treatment of serious lung diseases such as pulmonary infections in cystic fibrosis patients and cancers affecting the lung. The company is located in London, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Renu Vijaya